FREE Case Review (866) 588-0600

MDL Requested for Taxotere Hair Loss Lawsuits

The JPML is considering whether to form a multidistrict litigation (MDL) for alopecia claims related to the chemotherapy drug Taxotere.

A panel of judges is considering a proposal to consolidate all federal lawsuits alleging permanent hair loss, baldness and alopecia from the chemotherapy drug Taxotere (generic: docetaxel) into a multidistrict litigation (MDL) for pretrial handling.

Free Confidential Lawsuit Evaluation: If you or a loved one suffered hair loss, baldness or alopecia after chemo with Taxotere, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

September 28, 2016 – The U.S. Judicial Panel on Multidistrict Litigation (JPML) will hear oral arguments on the proposed consolidation today during a Hearing Session in Washington, D.C., according to court documents.

The U.S. Food & Drug Administration (FDA) approved Taxotere in 1996 for the treatment of breast cancer. FDA has since expanded the drug’s approval to include a number of cancers, including head and neck cancer, gastric cancer, prostate cancer and non-small cell lung cancer.

And though Taxotere has been on the U.S. market for 2 decades, it wasn’t until Dec. 2015 that any warning about permanent hair loss or “alopecia” was added to the drug’s labeling. More than 50 federal lawsuits have since been filed against drugmaker Sanofi-Aventis on behalf of women who allegedly suffered these side effects after undergoing chemotherapy with Taxotere.

While temporary hair loss is a common side effect of chemo, plaintiffs allege that Taxotere is more likely to result in alopecia compared to other equally effective cancer drugs. While Sanofi did warn about the potential for permanent hair loss overseas, the U.S. labeling only included a generic warning that “hair generally grows back,” according to the lawsuits.

In July, 2 plaintiffs filed a request with the JPML seeking consolidation of all federal Taxotere lawsuits in the U.S. District Court, Eastern District of Louisiana. While Sanofi agrees that centralization is appropriate, it has requested the U.S. District Court, District of New Jersey as the venue. The proposed MDL is In Re: Taxotere (Docetaxel) Products Liability Litigation – MDL No. 2740.

Do I Have a Taxotere Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Taxotere lawsuits. We are handling individual litigation nationwide and currently accepting new hair loss and alopecia cases in all 50 states.

Free Case Evaluation: Again, if you were injured by Taxotere, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition